Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | 0.0056 | 0.0742 | 0.0742 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0045 | 0.0533 | 0.0533 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0201 | 0.3607 | 0.3607 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.006 | 0.0824 | 0.0824 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0201 | 0.3607 | 0.3607 |
Mycobacterium ulcerans | flavodoxin reductase Hmp | 0.006 | 0.0824 | 0.0824 |
Echinococcus multilocularis | methionine synthase reductase | 0.0325 | 0.604 | 0.604 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.006 | 0.0824 | 0.0824 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0201 | 0.3607 | 0.3403 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0325 | 0.604 | 0.604 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0526 | 1 | 1 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | oxidoreductase-protein, putative | 0.006 | 0.0824 | 0.0824 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0201 | 0.3607 | 0.3033 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0526 | 1 | 1 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0201 | 0.3607 | 0.5 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0201 | 0.3607 | 0.3403 |
Brugia malayi | flavodoxin family protein | 0.0201 | 0.3607 | 0.3607 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.006 | 0.0824 | 0.0824 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0201 | 0.3607 | 0.5 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.006 | 0.0824 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0045 | 0.0533 | 0.0533 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Mycobacterium ulcerans | electron transfer protein FdxB | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | nitrate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Brugia malayi | FAD binding domain containing protein | 0.0325 | 0.604 | 0.604 |
Trypanosoma brucei | nitrate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Toxoplasma gondii | ferredoxin NADP+ oxidoreductase FNR | 0.006 | 0.0824 | 0.1722 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | cytochrome P450 reductase, putative | 0.0466 | 0.8823 | 0.8823 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0325 | 0.604 | 0.604 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0261 | 0.4784 | 1 |
Echinococcus granulosus | methionine synthase reductase | 0.0325 | 0.604 | 0.604 |
Leishmania major | NADH-dependent fumarate reductase-like protein | 0.006 | 0.0824 | 0.0824 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0201 | 0.3607 | 0.3607 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.006 | 0.0824 | 0.0824 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0526 | 1 | 1 |
Trypanosoma brucei | oxidoreductase-protein, putative | 0.006 | 0.0824 | 0.0824 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.018 | 0.018 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | NADH cytochrome b5 reductase 3 | 0.006 | 0.0824 | 0.0824 |
Brugia malayi | Cytochrome P450 family protein | 0.0045 | 0.0533 | 0.0533 |
Leishmania major | cytochrome-b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0201 | 0.3607 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0526 | 1 | 1 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Mycobacterium leprae | putative cytochrome p450 | 0.0018 | 0 | 0.5 |
Treponema pallidum | flavodoxin | 0.0201 | 0.3607 | 1 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.006 | 0.0824 | 0.0824 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0466 | 0.8823 | 0.8717 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0201 | 0.3607 | 0.3607 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0045 | 0.0533 | 0.0533 |
Toxoplasma gondii | NADH-cytochrome b5 reductase 1, putative | 0.006 | 0.0824 | 0.1722 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0036 | 0.0356 | 0.0356 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0526 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0045 | 0.0533 | 0.0533 |
Loa Loa (eye worm) | hypothetical protein | 0.0526 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0466 | 0.8823 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0526 | 1 | 1 |
Mycobacterium ulcerans | oxygenase | 0.006 | 0.0824 | 0.0824 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0262 | 0.0262 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0526 | 1 | 1 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0526 | 1 | 1 |
Mycobacterium ulcerans | monooxygenase | 0.006 | 0.0824 | 0.0824 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0201 | 0.3607 | 0.3403 |
Schistosoma mansoni | cytochrome B5 | 0.006 | 0.0824 | 0.0824 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.006 | 0.0824 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0036 | 0.0356 | 0.0356 |
Brugia malayi | FAD binding domain containing protein | 0.0526 | 1 | 1 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0261 | 0.4784 | 0.4784 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0261 | 0.4784 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0466 | 0.8823 | 0.8785 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0526 | 1 | 1 |
Schistosoma mansoni | NADH-cytochrome B5 reductase | 0.006 | 0.0824 | 0.0824 |
Brugia malayi | Cytochrome P450 family protein | 0.0045 | 0.0533 | 0.0533 |
Plasmodium vivax | hypothetical protein, conserved | 0.0201 | 0.3607 | 0.3033 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0201 | 0.3607 | 0.3607 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | cytochrome-b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0526 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0056 | 0.0742 | 0.0742 |
Brugia malayi | diaphorase | 0.006 | 0.0824 | 0.0824 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0466 | 0.8823 | 1 |
Mycobacterium tuberculosis | Possible oxygenase | 0.006 | 0.0824 | 1 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0045 | 0.0533 | 0.0533 |
Mycobacterium ulcerans | oxidoreductase | 0.006 | 0.0824 | 0.0824 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0039 | 0.0421 | 0.0421 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0526 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0045 | 0.0533 | 0.0533 |
Loa Loa (eye worm) | diaphorase | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Leishmania major | oxidoreductase-like protein | 0.006 | 0.0824 | 0.0824 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0526 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0526 | 1 | 1 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | reductase, putative | 0.006 | 0.0824 | 0.0824 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0201 | 0.3607 | 0.3033 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0526 | 1 | 1 |
Mycobacterium ulcerans | flavodoxin oxidoreductase | 0.006 | 0.0824 | 0.0824 |
Trypanosoma brucei | NADH-cytochrome b5 reductase-like protein | 0.006 | 0.0824 | 0.0824 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0201 | 0.3607 | 0.3403 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Chlamydia trachomatis | sulfite reductase | 0.0325 | 0.604 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0201 | 0.3607 | 0.3607 |
Leishmania major | nitrate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Onchocerca volvulus | 0.006 | 0.0824 | 0.5 | |
Entamoeba histolytica | type A flavoprotein, putative | 0.0201 | 0.3607 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0526 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0201 | 0.3607 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0039 | 0.0421 | 0.0421 |
Echinococcus granulosus | NADH cytochrome b5 reductase 3 | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | p450 reductase, putative | 0.006 | 0.0824 | 0.0824 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0036 | 0.0356 | 0.0356 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.006 | 0.0824 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0526 | 1 | 1 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Echinococcus multilocularis | cytochrome b5 reductase 4 | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | p450 reductase, putative | 0.0526 | 1 | 1 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.006 | 0.0824 | 0.0824 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0526 | 1 | 1 |
Leishmania major | cytochrome p450-like protein | 0.0045 | 0.0533 | 0.0533 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0526 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0045 | 0.0533 | 0.0533 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.006 | 0.0824 | 0.0824 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.006 | 0.0824 | 1 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0036 | 0.0356 | 0.0356 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0526 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0265 | 0.4863 | 0.4863 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.006 | 0.0824 | 0.0824 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.